DealBook: Third Point, Loeb’s Hedge Fund, Urges Amgen to Consider a Breakup

The hedge fund suggested that the drug maker consider splitting itself up into a faster-growing entity whose products require research spending, and a slower-growing company with more mature products.

via NYT > Business Day http://ift.tt/1w4DQhZ

via WordPress http://ift.tt/1oreY1C